Demetri GD - Search Results

1

Ecteinascidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: multicenter phase II and pharmacokinetic study.

Garcia-Carbonero R, Supko JG, Maki RG, Manola J, Ryan DP, Harmon D, Puchalski TA, Goss G, Seiden MV, Waxman A, Quigley MT, Lopez T, Sancho MA, Jimeno J, Guzman C, Demetri GD. Garcia-Carbonero R, et al. Among authors: demetri gd. J Clin Oncol. 2005 Aug 20;23(24):5484-92. doi: 10.1200/JCO.2005.05.028. J Clin Oncol. 2005. PMID: 16110008 Clinical Trial.

2

Hematopoietic growth factors and high-dose chemotherapy: will grams succeed where milligrams fail?

Demetri GD, Griffin JD. Demetri GD, et al. J Clin Oncol. 1990 May;8(5):761-4. doi: 10.1200/JCO.1990.8.5.761. J Clin Oncol. 1990. PMID: 1692086 No abstract available.

3

A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo.

Demetri GD, Spriggs DR, Sherman ML, Arthur KA, Imamura K, Kufe DW. Demetri GD, et al. J Clin Oncol. 1989 Oct;7(10):1545-53. doi: 10.1200/JCO.1989.7.10.1545. J Clin Oncol. 1989. PMID: 2506316

4

Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.

Demetri GD, Elias AD. Demetri GD, et al. Hematol Oncol Clin North Am. 1995 Aug;9(4):765-85. Hematol Oncol Clin North Am. 1995. PMID: 7490240 Review.

5

Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial.

Bajorin DF, Nichols CR, Schmoll HJ, Kantoff PW, Bokemeyer C, Demetri GD, Einhorn LH, Bosl GJ. Bajorin DF, et al. Among authors: demetri gd. J Clin Oncol. 1995 Jan;13(1):79-86. doi: 10.1200/JCO.1995.13.1.79. J Clin Oncol. 1995. PMID: 7799046 Clinical Trial.

6

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.

Tepler I, Cannistra SA, Frei E 3rd, Gonin R, Anderson KC, Demetri G, Niloff J, Goodman H, Muntz H, Muto M, et al. Tepler I, et al. J Clin Oncol. 1993 Aug;11(8):1583-91. doi: 10.1200/JCO.1993.11.8.1583. J Clin Oncol. 1993. PMID: 8101563

7

High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.

Demetri GD. Demetri GD. Semin Oncol. 1996 Jun;23(3 Suppl 6):22-6. Semin Oncol. 1996. PMID: 8677444 Review.

8

Chemotherapy and neutropenia.

Kim SK, Demetri GD. Kim SK, et al. Among authors: demetri gd. Hematol Oncol Clin North Am. 1996 Apr;10(2):377-95. doi: 10.1016/s0889-8588(05)70344-0. Hematol Oncol Clin North Am. 1996. PMID: 8707761 Review.

9

Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.

Shapiro CL, Ayash L, Webb IJ, Gelman R, Keating J, Williams L, Demetri G, Clark P, Elias A, Duggan D, Hayes D, Hurd D, Henderson IC. Shapiro CL, et al. J Clin Oncol. 1997 Feb;15(2):674-83. doi: 10.1200/JCO.1997.15.2.674. J Clin Oncol. 1997. PMID: 9053493

10

Angiosarcoma.

Vonderheide RH, Fleming MD, Carter G, Singer S, Demetri G. Vonderheide RH, et al. J Clin Oncol. 1997 Apr;15(4):1708-9. doi: 10.1200/JCO.1997.15.4.1708. J Clin Oncol. 1997. PMID: 9193372 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters